Below are the most recent publications written about "Palladium" by people in Profiles.
-
Xie S, Wang Z, Tan W, Zhu Y, Collier S, Ma L, Ehrlich SN, Xu P, Yan Y, Xu T, Deng J, Liu F. Highly Active and Stable Palladium Catalysts on Novel Ceria-Alumina Supports for Efficient Oxidation of Carbon Monoxide and Hydrocarbons. Environ Sci Technol. 2021 06 01; 55(11):7624-7633.
-
Shukla G, Sarkar A, Hanlon A, Crockett E, Chen HC, Martelli-Raben J, Glick A, Benge B, Lobis M, Terranova S, Desperito T, Cozzolino D, Kemmerer E, Mourtada F, Raben A. Biochemical control and toxicity for favorable- and intermediate-risk patients using real-time intraoperative inverse optimization prostate seed implant: Less is more! Brachytherapy. 2017 May - Jun; 16(3):490-496.
-
Sarkar A, Donavanik V, Zhang I, Chen H, Koprowski C, Hanlon A, Mourtada F, Strasser J, Raben A. Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds. Brachytherapy. 2013 Jul-Aug; 12(4):356-61.
-
Chiu-Tsao ST, Astrahan MA, Finger PT, Followill DS, Meigooni AS, Melhus CS, Mourtada F, Napolitano ME, Nath R, Rivard MJ, Rogers DW, Thomson RM. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. Med Phys. 2012 Oct; 39(10):6161-84.
-
Gupta RK, Pandey R, Singh R, Srivastava N, Maiti B, Saha S, Li P, Xu Q, Pandey DS. Heteroleptic dipyrrinato complexes containing 5-ferrocenyldipyrromethene and dithiocarbamates as coligands: selective chromogenic and redox probes. Inorg Chem. 2012 Aug 20; 51(16):8916-30.
-
Bhandarkar SS, Bromberg J, Carrillo C, Selvakumar P, Sharma RK, Perry BN, Govindarajan B, Fried L, Sohn A, Reddy K, Arbiser JL. Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo. Clin Cancer Res. 2008 Sep 15; 14(18):5743-8.
-
Hurwitz MD, Halabi S, Ou SS, McGinnis LS, Keuttel MR, Dibiase SJ, Small EJ. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809. Int J Radiat Oncol Biol Phys. 2008 Nov 1; 72(3):814-9.
-
Macmillan D, Anderson DW. Rapid synthesis of acyl transfer auxiliaries for cysteine-free native glycopeptide ligation. Org Lett. 2004 Dec 9; 6(25):4659-62.
-
Aboelella NW, York JT, Reynolds AM, Fujita K, Kinsinger CR, Cramer CJ, Riordan CG, Tolman WB. Mixed metal bis(mu-oxo) complexes with [CuM(mu-O)2]n+(M = Ni(III) or Pd(II)) cores. Chem Commun (Camb). 2004 Aug 7; (15):1716-7.
-
Chen CT, Waterman FM, Valicenti RK, Gomella LG, Strup SE, Dicker AP. Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy. Int J Cancer. 2001; 96 Suppl:83-8.